Key Points
- Director Amy Ladd sold 400 Intuitive Surgical shares at an average price of $379, generating $151,600 and reducing her direct ownership by 61.44%. The transaction was executed under a pre-arranged Rule 10b5-1 plan.
- Intuitive Surgical reported a strong quarter, with revenue up 18.4% year over year to $2.89 billion and EPS of $2.80, exceeding analysts’ $2.48 estimate.
- Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $509.02, although several firms recently lowered targets and concerns remain about valuation and slowing domestic procedure growth.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) Director Amy Ladd sold 72 shares of the business's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $393.10, for a total transaction of $28,303.20. Following the sale, the director owned 179 shares of the company's stock, valued at $70,364.90. This trade represents a 28.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Intuitive Surgical Trading Up 2.0%
Shares of ISRG stock opened at $401.23 on Wednesday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The stock has a market cap of $141.75 billion, a P/E ratio of 45.96, a P/E/G ratio of 2.84 and a beta of 1.46. The company has a 50 day simple moving average of $392.47 and a two-hundred day simple moving average of $443.35.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.83 billion. During the same quarter last year, the company posted $1.81 EPS. The company's revenue was up 18.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC lifted its stake in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider's stock worth $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. boosted its holdings in shares of Intuitive Surgical by 38.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider's stock valued at $529,000 after purchasing an additional 268 shares during the last quarter. Osterweis Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $200,000. Finally, Main Street Financial Solutions LLC boosted its stake in Intuitive Surgical by 92.4% during the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider's stock valued at $1,592,000 after buying an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.
Trending Headlines about Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Intuitive Surgical’s second-quarter results exceeded expectations: revenue rose 18.4% year over year to $2.89 billion, while EPS reached $2.80 versus the $2.48 consensus estimate. Higher margins, continued adoption of its da Vinci and Ion platforms, and long-term demand for robotic-assisted surgery support the bullish case. Intuitive Surgical Just Beat Earnings
- Positive Sentiment: A bullish investor cited Intuitive Surgical’s potential once-per-decade hardware replacement cycle and approximately $8.6 billion cash position, arguing that the more than 30% year-to-date decline could create an attractive long-term entry point. The Number One Reason I Keep Buying Intuitive Surgical
- Neutral Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus and an average price target of $509.02. However, several firms recently lowered their targets, reflecting greater caution after the earnings report.
- Neutral Sentiment: Reported short interest was zero shares, implying no measurable short-selling pressure. The figure appears unusual and may reflect incomplete or unreliable data rather than a meaningful market signal.
- Negative Sentiment: Despite the earnings beat, investors remain concerned about slowing domestic procedure growth and whether the company’s roughly 46 P/E adequately reflects its growth prospects. Those concerns have contributed to the stock’s recent weakness. Intuitive Surgical Earnings and Valuation Analysis
- Negative Sentiment: Director Amy L. Ladd sold 472 shares across August 10–11, reducing her holdings by a substantial percentage, while EVP Gary Loeb sold 400 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their significance as a discretionary bearish signal but may still weigh modestly on sentiment.
Wall Street Analyst Weigh In
A number of analysts have commented on the company. Royal Bank Of Canada reduced their price target on Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday, July 13th. Stifel Nicolaus lowered their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a "buy" rating on the stock in a report on Friday, July 17th. Piper Sandler set a $357.44 price target on shares of Intuitive Surgical in a research report on Monday, July 27th. BTIG Research reduced their price objective on shares of Intuitive Surgical from $512.00 to $469.00 and set a "buy" rating for the company in a research note on Friday, July 17th. Finally, BNP Paribas Exane upgraded shares of Intuitive Surgical to an "outperform" rating in a research report on Tuesday, July 28th. Twenty research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Intuitive Surgical has a consensus rating of "Moderate Buy" and a consensus target price of $509.02.
Get Our Latest Analysis on Intuitive Surgical
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
